Skip to main content

Table 3 Paired delta change and comparing the magnitude of change between non-obese and obese patients at the end of the program

From: Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease

Variable

Paired delta change for non-obese patients (n = 58)

Paired delta change for non-obese patients, p value

Paired delta change for obese patients (n = 62)

Paired delta change for obese patients, p value

Comparing the magnitude of change between non-obese and obese patients, p value

Clinical characteristics

 BMI, kg/m2

− 0.60 ± 0.70

< 0.001

− 1.78 ± 1.46

< 0.001

< 0.001

 Systolic BP, mmHg

− 3.62 ± 14.14

0.197

− 11.61 ± 10.68

< 0.001

0.016

 Diastolic BP, mmHg

0.17 ± 10.13

0.928

− 4.84 ± 8.11

0.002

0.038

 METs achieved

2.15 ± 1.07

< 0.001

1.85 ± 0.72

< 0.001

0.211

Laboratory tests

 Total cholesterol, mg/dl

− 32.46 ± 23.93

< 0.001

− 29.87 ± 18.56

< 0.001

0.641

 LDL-C, mg/dl

− 17.37 ± 13.28

< 0.001

− 25.76 ± 14.19

< 0.001

0.022

 HDL-C, mg/dl

4.66 ± 2.59

< 0.001

5.61 ± 1.31

< 0.001

0.073

 Triglycerides, mg/dl

− 26.37 ± 34.88

< 0.001

− 38.29 ± 34.55

< 0.001

0.189

 Fasting blood sugar, mg/dl

− 5.86 ± 8.05

< 0.001

− 7.26 ± 12.30

< 0.001

0.608

Echocardiographic parameters

 LVEDD, mm

− 0.21 ± 2.81

0.695

0.19 ± 1.87

0.569

0.516

 LVESD, mm

− 1.17 ± 2.16

0.007

− 0.13 ± 1.95

0.714

0.05

 LVEF, %

2.38 ± 2.93

< 0.001

0.74 ± 2.52

0.111

0.024

  1. Continuous variables are expressed as mean and standard deviation
  2. BMI body mass index, BP blood pressure, METs metabolic equivalent of tasks, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter, LVEF left ventricular ejection fraction